CBS and hyperhomocysteinemia: In the mouse model of CBS (+/−) hyperhomocysteinemia, homocysteine thiolactone, a highly reactive homocysteine metabolite has been demonstrated to directly affect eNOS by N- homocysteinylation and consequently reducing the bioavailability of NO.